Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Employment agrmnt
Quarterly results
Auditor change
Consulting agrmnt

PIERIS PHARMACEUTICALS, INC. (PIRS) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/30/2023 4 KIRITSY CHRISTOPHER P (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Bought 10,000 shares @ $0.85, valued at $8.5k
02/28/2023 4 Bures Thomas (CFO) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 249,080 options to buy @ $1.39, valued at $346.2k
02/28/2023 4 Kaufmann Hitto (Chief Scientific Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 249,080 options to buy @ $1.39, valued at $346.2k
02/28/2023 4 Mousa Ahmed (Chief Business Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 249,080 options to buy @ $1.39, valued at $346.2k
02/28/2023 4 Yoder Stephen S. (CEO) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 634,021 options to buy @ $1.39, valued at $881.3k
06/24/2022 4 Barbier Ann (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 40,000 options to buy @ $1.82, valued at $72.8k
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Kiener Peter A (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 40,000 options to buy @ $1.82, valued at $72.8k
06/24/2022 4 KIRITSY CHRISTOPHER P (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 40,000 options to buy @ $1.82, valued at $72.8k
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Sherman Matthew L (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 40,000 options to buy @ $1.82, valued at $72.8k
05/16/2022 4 Demuth Tim (Chief Medical Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Bought 6,000 shares @ $1.71, valued at $10.3k
02/24/2022 4 Demuth Tim (Chief Medical Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 100,000 options to buy @ $3.03, valued at $303k
02/24/2022 4 Mousa Ahmed (Chief Business Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 215,819 options to buy @ $3.03, valued at $653.9k
02/24/2022 4 Olwill Shane (Chief Development Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 215,819 options to buy @ $3.03, valued at $653.9k
02/24/2022 4 Bures Thomas (CFO) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 215,819 options to buy @ $3.03, valued at $653.9k
02/24/2022 4 Kaufmann Hitto (SVP, Chief Scientific Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 215,819 options to buy @ $3.03, valued at $653.9k
02/24/2022 4 Yoder Stephen S. (CEO) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 625,874 options to buy @ $3.03, valued at $1.9M
10/21/2021 3 Mousa Ahmed (Chief Business Officer) has filed a Form 3 on PIERIS PHARMACEUTICALS, INC.
09/01/2021 4 Olwill Shane (Chief Development Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Sold 9,200 shares @ $5, valued at $46k
Sold 29,200 shares @ $5.15, valued at $150.4k
Exercised 38,400 options to buy @ $1.52, valued at $58.4k
08/03/2021 4 Demuth Tim (Chief Medical Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 360,000 options to buy @ $3.48, valued at $1.3M
06/29/2021 4 Sherman Matthew L (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 40,000 options to buy @ $4, valued at $160k
06/29/2021 4 Said Maya R. (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 40,000 options to buy @ $4, valued at $160k
06/29/2021 4 Richman Michael (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 40,000 options to buy @ $4, valued at $160k
06/29/2021 4 KIRITSY CHRISTOPHER P (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 40,000 options to buy @ $4, valued at $160k
06/29/2021 4 Kiener Peter A (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 40,000 options to buy @ $4, valued at $160k
06/29/2021 4 GERAGHTY JAMES A (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 45,000 options to buy @ $4, valued at $180k
06/29/2021 4 Barbier Ann (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 40,000 options to buy @ $4, valued at $160k
03/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/22/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/25/2020 4/A KIRITSY CHRISTOPHER P (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 40,000 options to buy @ $3.27, valued at $130.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy